NDC 81033-412-30 - Potassium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-412
- Requested NDC
- 81033-412-30
- Package NDCs from labels
- 81033-412-15, 81033-412-51, 81033-412-50, 81033-412-30, 81033-412-32, 81033-412-34
- Manufacturer
- Kesin Pharma
- Effective date
- 2024-12-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Potassium Chloride - Kesin Pharma | Kesin Pharma | 2024-12-04 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-412-15 | Potassium Chloride | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 5 | |
| 81033-412-30 | Potassium Chloride | 30 mL in 1 CUP, UNIT-DOSE | SOLUTION | 30 | 5 | |
| 81033-412-32 | Potassium Chloride | 100 in 1 CASE | SOLUTION | 100 | 5 | |
| 81033-412-34 | Potassium Chloride | 50 in 1 CASE | SOLUTION | 50 | 5 | |
| 81033-412-50 | Potassium Chloride | 100 in 1 CASE | SOLUTION | 100 | 5 | |
| 81033-412-51 | Potassium Chloride | 50 in 1 CASE | SOLUTION | 50 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-412-15 | ML - Milliliter | 81033-412 | bbfbf218-c6fa-4f1f-a0b0-fd6c48577135 | 1 | 2024-08-12 |
| 81033-412-30 | ML - Milliliter | 81033-412 | b5400981-8240-485c-9d9f-87593850377e | 1 | 2024-08-12 |
| 81033-412-32 | ML - Milliliter | 81033-412 | 1d5cbd7d-98e5-4435-a285-be3bbff8b14a | 1 | 2024-08-12 |
| 81033-412-34 | ML - Milliliter | 81033-412 | ee33d2e1-7700-4f90-a7b5-9808c406891d | 1 | 2024-09-09 |
| 81033-412-50 | ML - Milliliter | 81033-412 | 3ec55d88-9e5c-430c-a4e9-fd74b75400de | 1 | 2024-08-12 |
| 81033-412-51 | ML - Milliliter | 81033-412 | a4c9fc82-8b5d-4db7-8def-ac8c2c3d5a44 | 1 | 2024-08-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | 7c2274f2-5a7f-4a4a-8b7b-44f6ef9a84a4 | 2025-09-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Polyethylene Glycol 3350 and electrolytes - Unflavored | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES - UNFLAVORED | Strides Pharma Science Limited | 48c741a9-9039-4fdb-a875-86d4ea968282 | 2025-09-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3dfa63fc-f8de-f1e0-e063-6294a90a8d47 | 2025-09-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3dfac7ca-2c2e-e709-e063-6394a90adbb3 | 2025-09-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Kesin Pharma Corporation | 440dcbbb-bb31-d3fd-e063-6294a90ab2f7 | 2025-09-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride - Unflavored | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE - UNFLAVORED | Strides Pharma Science Limited | 37c111ec-5b62-42b9-bbb2-3b0c530e34c9 | 2025-09-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Sterile Water | WATER INJECTION | Henry Schein, Inc. | 3501952b-b556-4d5e-b81b-5c35ff87b475 | 2025-08-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 8f6ea056-5e10-4de1-97f0-55f0655a6f78 | 2025-08-27 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 8757d093-747b-4e97-af6d-4064b16178b2 | 2025-08-27 | Warnings, Adverse reactions | 660YQ98I10 |
| Allergy and Sinus Relief | PELARGONIUM SIDOIDES ROOT, HYDRASTIS CANADENSIS WHOLE, POTASSIUM CHLORIDE, SANGUINARIA CANADENSIS ROOT, PULSATILLA VULGARIS, SILICON DIOXIDE | Schwabe North American, Inc. | c90cc6f5-14ec-41a3-a20a-4e8018bb02fb | 2025-08-25 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | American Health Packaging | 149770d0-3a2c-4e75-80a3-ec842907920d | 2025-08-25 | Warnings, Adverse reactions | 660YQ98I10 |
| Foaming Facial Cleanser | GLYCERIN, NIACINAMIDE | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c1db9-a5d3-cc82-e063-6294a90a90bb | 2025-08-23 | Warnings | PDC6A3C0OX |
| Refresh RELIEVA PF | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | d5d3df4a-a311-4f2d-9a24-edfec1a6c9f9 | 2025-08-22 | Warnings | PDC6A3C0OX |
| Refresh Optive | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 37e99aa8-02d6-4efb-a862-90bc7fcd5ca5 | 2025-08-22 | Warnings | PDC6A3C0OX |
| Upside Down Pain Relief | BENZOCAINE, GLYCERIN | Fridababy, LLC | 31c2cd25-1fec-5ec5-e063-6394a90a24b4 | 2025-08-15 | Warnings | PDC6A3C0OX |
| Schuessler Tissue Salts Comb D Skin Disorders | KALI MURIATICUM,KALI SULPHURICUM,CALCAREA SULPHURICA,SILICEA | Martin & Pleasance Pty Ltd | 617303f8-4463-4a1e-a502-44abc181d91f | 2025-08-13 | Warnings | 660YQ98I10 |
| Schuessler Tissue Salts Comb D Skin Disorders | KALI MURIATICUM,KALI SULPHURICUM,CALCAREA SULPHURICA,SILICEA | Martin & Pleasance Pty Ltd | 03153d92-dc68-4b84-a8c9-634b1ffd7da1 | 2025-08-13 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Henry Schein, Inc. | bf8e8ac7-e6a8-4571-a0ea-7bcab89290f6 | 2025-08-12 | Warnings, Adverse reactions | 660YQ98I10 |
| Norms Hemorrhoid | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Totally Normal Company | 3bdf8c74-3db6-1805-e063-6394a90aaba0 | 2025-08-08 | Warnings | PDC6A3C0OX |
| Potassium Chloride | POTASSIUM CHLORIDE | AvKARE | 3bdfced1-6e62-9e92-e063-6294a90a28aa | 2025-08-08 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.